CD31/PECAM‐1‐driven chemokine‐independent transmigration of human T lymphocytes
CD31/PECAM‐1‐driven chemokine‐independent transmigration of human T lymphocytes
复制标题
CD31/PECAM-1驱动的不依赖趋化因子的人T淋巴细胞迁移
DOI:
--
复制
发表时间:
1996
影响因子:
5.4
通讯作者:
R. Pardi
中科院分区:
文献类型:
--
作者:
M. Zocchi;E. Ferrero;B. Leone;P. Rovere;E. Bianchi;E. Toninelli;R. Pardi
We assessed the relative contribution of CD31/PECAM‐1 (platelet‐endothelial cell adhesion molecule‐1) to T lymphocyte transmigration by the use of transfected murine fibroblasts stably expressing either the human CD31/PECAM‐1 or the intercellular adhesion molecule‐1 (CD54/ICAM‐1). Unlike CD54/ICAM‐1, CD31/PECAM‐1 supported migration of activated T cells in the absence of chemokines: most of the migrating lymphocytes were CD31+ and displayed a phenotype corresponding to the naive subpopulation (LFA‐1dull and CD45RA+). Migration of activated T lymphocytes through CD54/ICAM‐1+ transfected monolayers could be induced by creating a chemotactic gradient with the chemokine monocyte chemotactic protein‐1, and the migrating cells mainly displayed a memory phenotype (LFA‐1brightCD45RO+) under these conditions. Furthermore, we found that in transfected cells CD54/ICAM‐1 is uniformly distributed along the apical surface of the cells, while CD31/PECAM‐1 is concentrated at the intercellular junctions, suggesting the existence of a haptotactic gradient (i.e. a gradient of substrate‐ or cell‐bound molecules) responsible for T cell migration. This was also confirmed by the finding that monolayers of murine fibroblasts transfected with a CD31/PECAM‐1 mutant lacking the cytoplasmic domain (CD31/PECAM‐1‐Δcyto), which has a reduced tendency to localize at cell‐cell contact areas, supported efficient adhesion but were unable to induce migration of activated T cells unless a chemotactic gradient was created. We propose that in lymphocytes, homophilic CD31/PECAM‐1 adhesion may be primarily involved in transmigration of naive T cells and that its role is complementary to that of CD54/ICAM‐1.
登录
查看更多内容
DOI:
10.1172/jci113007
发表时间:
1987
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Bender,JR;Pardi,R;Karasek,MA;Engleman,EG
通讯作者:
Engleman,EG
影响因子:
4.4
作者:
P. Parham
通讯作者:
P. Parham
影响因子:
20.3
作者:
T. Carlos;J. Harlan
通讯作者:
T. Carlos;J. Harlan
DOI:
10.1073/pnas.91.9.3652
发表时间:
1994-04-26
影响因子:
11.1
作者:
CARR, MW;ROTH, SJ;SPRINGER, TA
通讯作者:
SPRINGER, TA
影响因子:
29.7
作者:
L. Picker;E. Butcher
通讯作者:
L. Picker;E. Butcher